Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma
Clinical trial NCT03952572 · UNKNOWN
Trial details
- NCT number
- NCT03952572
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-10
- Primary completion
- 2023-04-30
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.